Medical/Pharmaceuticals

Enhancing the Quality of Dense Breast Imaging Solutions Spurs Growth Opportunities for the US Market

MOUNTAIN VIEW, Calif., April 14, 2016 /PRNewswire/ -- Nearly one in eight women in the U.S. is diagnosed with breast cancer, making it the most commonly diagnosed cancer and the second largest cause of death among American women. This vast patient pool is encouraging manufacturers of breast imagi...

2016-04-14 21:35 1748

Sunway University's Professor Naveed Khan Awarded Science Academy Gold Medal

BANDAR SUNWAY, Malaysia, April 13, 2016 /PRNewswire/ -- In recognition of his outstanding research work in Biological Sciences, Sunway University's Professor Naveed Khan was awarded the prestigious Pakistan Academy of Sciences (PAS) Gold Medal inNovember 2015. Simple yet fascinating, his research ...

2016-04-13 10:00 2680

ArisGlobal(R) Announces Record Growth in 2015

CHICAGO, April 12, 2016 /PRNewswire/ -- ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, today announced it achieved record growth, market expansion, and major product innovations in 2015. The company has robust plans in place to continually innovate its life s...

2016-04-12 08:00 1813

NMT Pharmaceuticals Singapore Announces Signing of Licensing Agreement with CAO Pharmaceuticals USA on Anti-cancer Drug CZ-48 and Initiation of Phase I Study

SINGAPORE, April 11, 2016 /PRNewswire/ -- NMT Pharmaceuticals Pte Ltd (NMT Pharma) announced today that it has signed a licensing agreement with US-based CAO Pharmaceuticals Inc. (CAO Pharma) for an exclusive worldwide license right to further develop and market an anti-cancer drug CZ-48 co-devel...

2016-04-11 20:00 2140

Official Launch of BookDoc - The Trusted Medical Companion for Tourists

KUALA LUMPUR, Malaysia, April 11, 2016 /PRNewswire/ -- BookDoc enables better access to healthcare for tourists and supports the medical tourism market with entry into another ASEAN country,Thailand. Y.Bhg Tan Sri Dr Ong Hong Peng ...

2016-04-11 09:00 2869

Nextgen2016 Will Convene on April 12-13 in Shanghai

SHANGHAI, April 8, 2016 /PRNewswire/ -- Hosted by UBM China & CPhI China, the world's largest pharmaceutical APIs expo, and co-organized byShanghai's Pudong Financial Services Association of Science and Technology, Nextgen2016  will convene on April 12-1...

2016-04-08 18:09 2732

Drive to Increase Local Production of Drugs Presents Vast Opportunities for Ethiopian Pharmaceuticals

CAPE TOWN, South Africa, April 6, 2016 /PRNewswire/ -- The Government of Ethiopia is offering tax and loan incentives to encourage local pharmaceutical production that will ultimately reduce the cost of drugs, increase job opportunities, improve economic growth and enhance foreign exchange inflow...

2016-04-06 14:30 1464

Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients

DARMSTADT, Germany, April 6, 2016 /PRNewswire/ -- * Novel liquid biopsy RAS testing now available to clinical practices for m etastatic colorectal cancer (mCRC) patients  * The test will help guide physicians to select the most effective treatment for mCRC patients in a timely manner  Merck, ...

2016-04-06 14:15 2007

Global Campaign Launches to Help the World to See www.clearly.world

HONG KONG, April 6, 2016 /PRNewswire/ -- 'Clearly' Campaign Aims To Unlock The Next Revolutionary Approaches To Eye Care For The People Who Need It Most  There are 2.5 billion people around the world suffering from poor vision and no means of improving it. A new global campaign - Clearly - laun...

2016-04-06 09:00 1836

Interventional Spine, Inc. announces New Line of Opticage® Lumbar Interbody Fusion Implants

IRVINE, Calif., April 5, 2016 /PRNewswire/ -- Interventional Spine, Inc. today announced the launch of a new line of products that will be showcased at this year's International Society for the Advancement of Spine Surgery (ISASS) Annual Meeting inLas Vegas, NV. The new products, available at exh...

2016-04-05 23:37 2558

Biodist and Seegene Establish Joint Venture in Mexico

SEOUL, South Korea, April 5, 2016 /PRNewswire/ -- Biodist SA de CV., a leader in molecular solutions inMexico, and Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies in Korea, are establishing a Joint Venture ("JV") inMexico to target the Mexico and central and southern A...

2016-04-05 21:00 3065

LKK Health Products Group Honored with "Outstanding CSR Award" for Five Consecutive Years

HONG KONG, April 5, 2016 /PRNewswire/ -- On March 30, LKK Health Products Group (LKKHPG) claimed the "Outstanding CSR Award" for the fifth consecutive year at the award presentation ceremony organized byThe Mirror, an authoritative monthly magazine based inHong Kong.

2016-04-05 20:46 2130

Sorrento Announces Definitive Agreements for up to $150 Million Private Placement

SAN DIEGO, April 5, 2016 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs company, today announced that it has entered into definitive agreements with instit...

2016-04-05 08:55 1998

AkesoCare Unveils New Corporate Branding

INDIANAPOLIS, April 5, 2016 /PRNewswire/ -- Akeso Care Management® ("AkesoCare"), a URAC-accredited international health care management company, has unveiled new corporate branding to reflect its commitment to clients. AkesoCare's new logo evokes a sense of optimism and passion -- the same tr...

2016-04-05 06:05 1410

Saxenda(R) demonstrated significant improvements in cardiometabolic risk factors over three years compared with placebo

BOSTON, April 5, 2016 /PRNewswire/ -- For non-US medical media only. For journalistic assessment and preparation before publication. Oral Presentation# OR36-1 Today, new data from the three-year part of the phase 3a SCALE™ (Satiety and C linicalAdiposity - Liraglutide Evidence) Obesity and Pred...

2016-04-05 01:03 1913

Athenex Announces the Addition of David Cutler, MD, FRCP(C) to its Global Clinical Development Team

BUFFALO, N.Y. and HONG KONG, April 4, 2016 /PRNewswire/ -- Athenex, Inc. announced today thatDavid Cutler, MD, FRCP(C), has joined Athenex as Vice President of Clinical Development working together with Dr. Rudolf Kwan, Chief Medical Officer. Dr. Cutler has extensive expertise in oncology drug d...

2016-04-04 22:15 1748

Victoza® (liraglutide 1.8 mg) Provided Superior HbA1c Reductions in Adults with Type 2 Diabetes Compared to Continued Sitagliptin Treatment

BOSTON, April 3, 2016 /PRNewswire/ -- For non-US medical media only.      For journalistic assessment and preparation before publication.      Abstract #689-P   Findings from a clinical trial comparing Victoza® (liraglutide 1.8 mg) and sitagliptin (100 mg), both in combination with metformin, ...

2016-04-03 01:15 2242

Semaglutide Demonstrated Superior Improvements In Glycaemic Control Vs Placebo In Adults With Type 2 Diabetes

BOSTON, April 2, 2016 /PRNewswire/ -- For non-US medical media only.  For journalistic assessment and preparation before publication. Abstract #OR15-1   Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated th...

2016-04-02 23:45 2216

Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in Asian Patients with Refractory Metastatic Colorectal Cancer

TOKYO, April 1, 2016 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. of Tokyo announced onApril 1 results from its Phase III TERRA study on its oral combination anticancer drug TAS-102 (product name inJapan and the US LONSURF (R), nonproprietary names: trifluridine (FTD) and tipiracil (TPI)) in As...

2016-04-01 15:00 3472

SIR-Spheres(R) Y-90 Resin Microspheres Are a Well-Tolerated Alternative to Standard Therapies for Inoperable Primary Liver Cancer, New UK NICE Medtech Innovation Briefing Says

LONDON, March 31, 2016 /PRNewswire-FirstCall/ -- Sirtex (ASX: SRX) announced today that the UK National Institute for Health and Care Excellence (NICE) has issued a new Medtech Innovation Briefing (MIB)[1] stating that NHS doctors and commissioners may consider SIR-SpheresY-90 resin microspheres ...

2016-03-31 19:20 2524
1 ... 136137138139140141142 ... 144